Stock Report

Gland Pharma Ltd Q2FY22 consolidated PAT slips QoQ to Rs. 302.08 crore



Posted On : 2021-10-22 17:27:42( TIMEZONE : IST )

Gland Pharma Limited has reported Consolidated financial results for the period ended September 30, 2021.

Financial Results (Q2 FY2022) - QoQ Comparison

The company has reported total income of Rs. 1131.666 crores during the period ended September 30, 2021 as compared to Rs. 1215.738 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs. 302.081 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 350.652 crores for the period ended June 30, 2021.

The company has reported EPS of Rs. 18.37 for the period ended September 30, 2021 as compared to Rs. 21.37 for the period ended June 30, 2021.

Financials Q2 FY2022 Q1 FY2022 % Change
Total Income ₹ 1131.666 crs ₹1215.738 crs Up Tick / Down Tick-6.92%
Net Profit ₹302.081 crs ₹350.652 crs Up Tick / Down Tick-13.85%
EPS ₹18.37 ₹21.37 Up Tick / Down Tick-14.04%

Financial Results (Q2 FY2022) - YoY Comparison

The company has reported total income of Rs. 1131.666 crores during the period ended September 30, 2021 as compared to Rs.851.852 crores during the period ended September 30, 2020.

The company has posted net profit / (loss) of Rs.302.081 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.218.857 crores for the period ended September 30, 2020.

The company has reported EPS of Rs.18.37 for the period ended September 30, 2021 as compared to Rs.14.12 for the period ended September 30, 2020.

Financials Q2 FY2022 Q2 FY2021 % Change
Total Income ₹ 1131.666 crs ₹851.852 crs Up Tick / Down Tick32.85%
Net Profit ₹302.081 crs ₹218.857 crs Up Tick / Down Tick38.03%
EPS ₹18.37 ₹14.12 Up Tick / Down Tick30.10%

Financial Results (Half Year Ended FY2022) - YoY Comparison

The company has reported total income of Rs.2347.404 crores during the 6 Months period ended September 30, 2021 as compared to Rs.1768.141 crores during the 6 Months period ended September 30, 2020.

The company has posted net profit / (loss) of Rs.652.733 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.532.447 crores for the 6 Months period ended September 30, 2020.

The company has reported EPS of Rs.39.78 for the 6 Months period ended September 30, 2021 as compared to Rs.34.36 for the 6 Months period ended September 30, 2020.

Financials Half Year Ended FY2022 Half Year Ended FY2021 % Change
Total Income ₹2347.404 crs ₹1768.141 crs Up Tick / Down Tick32.76%
Net Profit ₹652.733 crs ₹532.447 crs Up Tick / Down Tick22.59%
EPS ₹39.78 ₹34.36 Up Tick / Down Tick15.77%

Shares of Gland Pharma Limited was last trading in BSE at Rs. 3693.65 as compared to the previous close of Rs. 3617.90. The total number of shares traded during the day was 8747 in over 2692 trades.

The stock hit an intraday high of Rs. 3720.00 and intraday low of 3584.70. The net turnover during the day was Rs. 32096598.00.

Source : Equity Bulls

Keywords

GlandPharma Q2FY22 H1FY22 ResultUpdate